Veristat expands regulatory and clinical services to Chinese drugmakers

Veristat, a US headquartered clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to international pharmaceutical and medical device companies seeking a streamlined path into European, including the UK and Switzerland, plus Australian, Canadian, and US markets.

Particularly, Veristat has helped many Chinese companies – including Hansoh Pharma and CStone Pharmaceuticals – successfully navigate regional regulatory requirements and legal complexities leading to product approvals. Now, Veristat is expanding to provide comprehensive regional clinical trial support.